| Non-viral gene therapy: Gains and challenges of non-invasive administration methods M Foldvari, DW Chen, N Nafissi, D Calderon, L Narsineni, A Rafiee Journal of Controlled Release 240, 165-190, 2016 | 267 | 2016 |
| Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems A Hakim, B Guido, L Narsineni, DW Chen, M Foldvari Advanced drug delivery reviews 196, 114781, 2023 | 18 | 2023 |
| Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development DW Chen, L Narsineni, M Foldvari Nanomedicine: Nanotechnology, Biology and Medicine 21, 102045, 2019 | 7 | 2019 |
| Dicationic amino substituted gemini surfactants and their nanoplexes: improved synthesis and characterization of transfection efficiency and corneal penetration in vitro L Narsineni, M Foldvari Pharmaceutical Research 37 (7), 144, 2020 | 6 | 2020 |
| BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexesin vivo L Narsineni, DW Chen, M Foldvari Journal of Ophthalmology Clinics and Research 359, 244-256, 2023 | 5 | 2023 |
| Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation … L Narsineni, PPN Rao, AT Pham, M Foldvari Molecular Pharmaceutics 19 (8), 2737-2753, 2022 | 2 | 2022 |
| Evaluation of transfection with gemini nanoparticles for retinal neuroprotection in a dynamic microfluidic cell culture system L Narsineni, A Hakim, B Guido, M Foldvari Precision Nanomedicine 7 (1), 1264-1278, 2024 | | 2024 |
| Development of Multi-Functionalized Gemini Nanoplexes for Non-Viral Neurotrophic Factor Gene Delivery to the Retina L Narsineni, DWR Chen, M Foldvari MOLECULAR THERAPY 28 (4), 471-472, 2020 | | 2020 |
| Development of Peptide-Modified Gemini Nanoplexes for Gene Delivery to the Retina L Narsineni University of Waterloo, 2020 | | 2020 |
